Sponsor or institution
Clinical trials and research at Dompé Farmaceutici S.p.A
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Dompé Farmaceutici S.p.A that are recruiting, at sites in 15 countries (most in United States (4), Italy (2), South Korea (2)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 15Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Efficacy and safety of cenegermin eye drops for persistent corneal epithelial defects | Phase 3 | Huntington Beach, California and 76 other locations | Recruiting | Apr 9, 2026 |
| Topical eye drop for dry eye disease in adults | Phase 2 | Chandler, Arizona and 23 other locations | Recruiting | Mar 31, 2026 |
| Intranasal cenegermin for NAION in adults | Phase 3 | Los Angeles, California and 37 other locations | Recruiting | Mar 6, 2026 |
| DFL24498 for treating atopic keratoconjunctivitis (AKC) | Phase 3 | Jacksonville, Florida and 18 other locations | Recruiting | Feb 9, 2026 |
All recruiting trials (4)
-
Efficacy and safety of cenegermin eye drops for persistent corneal epithelial defects
This study tests whether cenegermin eye drops can heal persistent corneal epithelial defects better than a vehicle in adults with PCED.
-
Topical eye drop for dry eye disease in adults
This phase 2 trial tests whether DFL24498 eye drops improve symptoms of dry eye disease compared with a non-medicated vehicle in adults 18 and older.
-
Intranasal cenegermin for NAION in adults
This study tests whether intranasal cenegermin can help adults with non-arteritic anterior ischemic optic neuropathy compared with a placebo-like vehicle.
-
DFL24498 for treating atopic keratoconjunctivitis (AKC)
This will test whether DFL24498 eye drops reduce inflammation and symptoms in adults aged 18–65 with chronic atopic keratoconjunctivitis compared with a vehicle eye drop.
Quick answers
How many clinical trials run by Dompé Farmaceutici S.p.A are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (4 trials), Italy (2 trials), South Korea (2 trials), Spain (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.